Cerezyme (Genzyme Corporation)
Welcome to the PulseAid listing for the Cerezyme drug offered from Genzyme Corporation. This Glucosylceramidase [Chemical/Ingredient],Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genzyme Corporation |
NON-PROPRIETARY NAME: | IMIGLUCERASE |
SUBSTANCE NAME: | IMIGLUCERASE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Glucosylceramidase [Chemical/Ingredient],Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1994-05-23 |
END MARKETING DATE: | 0000-00-00 |
Cerezyme HUMAN PRESCRIPTION DRUG Details:
Item Description | Cerezyme from Genzyme Corporation |
LABELER NAME: | Genzyme Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(U/mL) |
START MARKETING DATE: | 1994-05-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58468-1983_50ade44e-9936-4fdb-b58c-f1ce6e4db53c |
PRODUCT NDC: | 58468-1983 |
APPLICATION NUMBER: | NDA020367 |
Other IMIGLUCERASE Pharmaceutical Manufacturers / Labelers: